Protein movement during complex-formation between tissue plasminogen activator and plasminogen activator inhibitor-1

被引:7
作者
Björquist, P [1 ]
Ehnebom, J [1 ]
Deinum, J [1 ]
机构
[1] AB Hassle, Preclin Res & Dev, Dept Cell Biol & Biochem, S-43183 Molndal, Sweden
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 1999年 / 1431卷 / 01期
关键词
antibody; fibrinolysis; plasminogen activator; plasminogen activator inhibitor; serpin; surface plasmon resonance;
D O I
10.1016/S0167-4838(99)00031-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasminogen activator inhibitor-1 (PAI-1) rapidly inactivates tissue plasminogen activator (tPA). After initial binding and cleavage of the reactive-centre loop of PAI-1, this complex is believed to undergo a major rearrangement. Using surface plasmon resonance and SDS-PAGE, we have studied the influence of a panel of monoclonal antibodies on the reaction leading to the final covalent complex. On the basis of these data, we suggest the mechanisms for the action of different classes of inhibitory antibodies. We propose that the antibodies which convert PAI-1 into a substrate for tPA do this by means of preventing the conversion of the initial PAI-1/tPA complex into the final complex by sterical intervention. Moreover, the localisation of the binding epitopes on free PAI-1, as well as on the PAI-1/tPA complex, suggests that tPA in the final complex cannot be located near helices E and F, as has previously been proposed. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:24 / 29
页数:6
相关论文
共 35 条
[1]  
Abrahamsson T, 1996, THROMB HAEMOSTASIS, V75, P118
[2]   Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases [J].
Aertgeerts, K ;
DeRanter, CJ ;
Booth, NA ;
Declerck, PJ .
JOURNAL OF STRUCTURAL BIOLOGY, 1997, 118 (03) :236-242
[3]   MECHANISMS CONTRIBUTING TO THE CONFORMATIONAL AND FUNCTIONAL FLEXIBILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
AERTGEERTS, K ;
DEBONDT, HL ;
DERANTER, CJ ;
DECLERCK, PJ .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (10) :891-897
[4]  
ASAKURA S, 1989, J BIOL CHEM, V264, P13736
[5]   THROMBOLYSIS AND REOCCLUSION IN EXPERIMENTAL JUGULAR-VEIN AND CORONARY-ARTERY THROMBOSIS - EFFECTS OF A PLASMINOGEN-ACTIVATOR INHIBITOR TYPE 1-NEUTRALIZING MONOCLONAL-ANTIBODY [J].
BIEMOND, BJ ;
LEVI, M ;
CORONEL, R ;
JANSE, MJ ;
TENCATE, JW ;
PANNEKOEK, H .
CIRCULATION, 1995, 91 (04) :1175-1181
[6]  
BJORK I, 1993, BIOCHEMISTRY-US, V32, P6501
[7]   PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 INTERACTS EXCLUSIVELY WITH THE PROTEINASE DOMAIN OF TISSUE-PLASMINOGEN ACTIVATOR [J].
BJORQUIST, P ;
BROHLIN, M ;
EHNEBOM, J ;
ERICSSON, M ;
KRISTIANSEN, C ;
POHL, G ;
DEINUM, J .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1994, 1209 (02) :191-202
[8]   Epitopes on plasminogen activator inhibitor type-1 important for binding to tissue plasminogen activator [J].
Bjorquist, P ;
Ehnebom, J ;
Inghardt, T ;
Deinum, J .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1341 (01) :87-98
[9]   Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis [J].
Björquist, P ;
Ehnebom, J ;
Inghardt, T ;
Hansson, L ;
Lindberg, M ;
Linschoten, M ;
Strömqvist, M ;
Deinum, J .
BIOCHEMISTRY, 1998, 37 (05) :1227-1234
[10]   PROTEINASE - PROTEIN INHIBITOR INTERACTIONS [J].
BODE, W ;
HUBER, R .
FIBRINOLYSIS, 1994, 8 :161-171